Tafenoquine for the prevention of Plasmodium vivax malaria relapse

Lancet Microbe. 2021 May;2(5):e175-e176. doi: 10.1016/S2666-5247(21)00062-8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aminoquinolines / therapeutic use
  • Humans
  • Malaria, Vivax* / drug therapy
  • Primaquine
  • Recurrence

Substances

  • Aminoquinolines
  • tafenoquine
  • Primaquine